125 related articles for article (PubMed ID: 7705954)
21. Therapeutic effect of the gastrin receptor antagonist, CR2093 on gastrointestinal tumour cell growth.
Watson SA; Crosbee DM; Morris DL; Robertson JF; Makovec F; Rovati LC; Hardcastle JD
Br J Cancer; 1992 Jun; 65(6):879-83. PubMed ID: 1616859
[TBL] [Abstract][Full Text] [Related]
22. Heptadecapeptide gastrin: measurement in blood by specific radioimmunoassay.
Dockray GJ; Taylor IL
Gastroenterology; 1976 Dec; 71(6):971-7. PubMed ID: 992280
[TBL] [Abstract][Full Text] [Related]
23. Gastrin receptors on isolated canine parietal cells.
Soll AH; Amirian DA; Thomas LP; Reedy TJ; Elashoff JD
J Clin Invest; 1984 May; 73(5):1434-47. PubMed ID: 6325503
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of the gastrin receptor antagonist (L-365,260) on gastrointestinal tumor cells.
Watson S; Durrant L; Elston P; Morris D
Cancer; 1991 Sep; 68(6):1255-60. PubMed ID: 1873778
[TBL] [Abstract][Full Text] [Related]
25. G17DT--a new weapon in the therapeutic armoury for gastrointestinal malignancy.
Watson SA; Gilliam AD
Expert Opin Biol Ther; 2001 Mar; 1(2):309-17. PubMed ID: 11727538
[TBL] [Abstract][Full Text] [Related]
26. Inhibition of gastrin-stimulated growth of gastrointestinal tumour cells by octreotide and the gastrin/cholecystokinin receptor antagonists, proglumide and lorglumide.
Watson SA; Morris DL; Durrant LG; Robertson JF; Hardcastle JD
Eur J Cancer; 1992; 28A(8-9):1462-7. PubMed ID: 1355350
[TBL] [Abstract][Full Text] [Related]
27. Molecular mechanisms for the antiapoptotic action of gastrin.
Todisco A; Ramamoorthy S; Witham T; Pausawasdi N; Srinivasan S; Dickinson CJ; Askari FK; Krametter D
Am J Physiol Gastrointest Liver Physiol; 2001 Feb; 280(2):G298-307. PubMed ID: 11208554
[TBL] [Abstract][Full Text] [Related]
28. Autocrine stimulation of growth of AR4-2J rat pancreatic tumour cells by gastrin.
Blackmore M; Hirst BH
Br J Cancer; 1992 Jul; 66(1):32-8. PubMed ID: 1637673
[TBL] [Abstract][Full Text] [Related]
29. Importance of N- and C-terminal regions of gastrin-Gly for preferential binding to high and low affinity gastrin-Gly receptors.
Ahmed S; Murphy RF; Lovas S
Peptides; 2005 Jul; 26(7):1207-12. PubMed ID: 15949639
[TBL] [Abstract][Full Text] [Related]
30. Immunocytochemical evidence for differential distribution of gastrin forms using region-specific monoclonal antibodies.
Azuma T; Abrahm D; Walsh JH
Gastroenterol Jpn; 1986 Aug; 21(4):319-24. PubMed ID: 3770352
[TBL] [Abstract][Full Text] [Related]
31. Metabolism of heptadecapeptide gastrin in humans studied by region-specific antisera.
Pauwels S; Dockray GJ; Walker R; Marcus S
J Clin Invest; 1985 Jun; 75(6):2006-13. PubMed ID: 2409113
[TBL] [Abstract][Full Text] [Related]
32. The apoptosis-inducing effect of gastrin on colorectal cancer cells relates to an increased IEX-1 expression mediating NF-kappa B inhibition.
Sebens Müerköster S; Rausch AV; Isberner A; Minkenberg J; Blaszczuk E; Witt M; Fölsch UR; Schmitz F; Schäfer H; Arlt A
Oncogene; 2008 Feb; 27(8):1122-34. PubMed ID: 17704804
[TBL] [Abstract][Full Text] [Related]
33. Antiserum raised against an epitope of the cholecystokinin B/gastrin receptor inhibits hepatic invasion of a human colon tumor.
Watson SA; Clarke PA; Morris TM; Caplin ME
Cancer Res; 2000 Oct; 60(20):5902-7. PubMed ID: 11059789
[TBL] [Abstract][Full Text] [Related]
34. Gastrin sensitivity of primary human colorectal cancer: the effect of gastrin receptor antagonism.
Watson SA; Clifford T; Sykes RE; Robinson E; Steele RJ
Eur J Cancer; 1995 Nov; 31A(12):2086-92. PubMed ID: 8562170
[TBL] [Abstract][Full Text] [Related]
35. Glycine-extended gastrin synergizes with gastrin 17 to stimulate acid secretion in gastrin-deficient mice.
Chen D; Zhao CM; Dockray GJ; Varro A; Van Hoek A; Sinclair NF; Wang TC; Koh TJ
Gastroenterology; 2000 Sep; 119(3):756-65. PubMed ID: 10982770
[TBL] [Abstract][Full Text] [Related]
36. Gastrin suppresses growth of CCK2 receptor expressing colon cancer cells by inducing apoptosis in vitro and in vivo.
Müerköster S; Isberner A; Arlt A; Witt M; Reimann B; Blaszczuk E; Werbing V; Fölsch UR; Schmitz F; Schäfer H
Gastroenterology; 2005 Sep; 129(3):952-68. PubMed ID: 16143134
[TBL] [Abstract][Full Text] [Related]
37. Immunogenicity and safety of a novel tetanus toxoid-conjugated anti-gastrin vaccine in BALB/c mice.
He Q; Gao H; Gao M; Qi S; Yang K; Zhang Y; Wang J
Vaccine; 2018 Feb; 36(6):847-852. PubMed ID: 29306507
[TBL] [Abstract][Full Text] [Related]
38. Gastrin: growth enhancing effects on human gastric and colonic tumour cells.
Watson S; Durrant L; Morris D
Br J Cancer; 1989 Apr; 59(4):554-8. PubMed ID: 2713241
[TBL] [Abstract][Full Text] [Related]
39. Gastric acid secretion is abnormally sensitive to endogenous gastrin released after peptone test meals in duodenal ulcer patients.
Lam SK; Isenberg JI; Grossman MI; Lane WH; Walsh JH
J Clin Invest; 1980 Feb; 65(2):555-62. PubMed ID: 7356694
[TBL] [Abstract][Full Text] [Related]
40. Effects of somatostatin analogue RC-160 and bombesin/gastrin-releasing peptide antagonists on the growth of human small-cell and non-small-cell lung carcinomas in nude mice.
Pinski J; Schally AV; Halmos G; Szepeshazi K; Groot K; O'Byrne K; Cai RZ
Br J Cancer; 1994 Nov; 70(5):886-92. PubMed ID: 7947094
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
